HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for neurofibromatosis alive. This method could work for “every rare disease under ...